Skip to main content

BARCLAYS PLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 312069 LONDON, X0

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$473,326
+$28,728 QoQ
Shares Held
27,892
-7.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#135
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Derivatives in AUPH

reported options exposure · as of Mar 31, 2024
CallValue
$212,925
CallShares
42,500
PutValue
$212,925
PutShares
42,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. AUPH ranks #170 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $473,326 27,892
2026-03-31 $444,598 30,000
2025-12-31 $2,968,932 186,140
2025-09-30 $1,896,179 171,600
2025-06-30 $2,120,209 250,320
2025-03-31 $1,435,405 178,533
2024-12-31 $2,190,653 243,948
2024-09-30 $1,607,696 219,331
2024-06-30 $435,438 76,259
2024-03-31 $212,925 42,500
2024-03-31 $212,925 42,500
2024-03-31 $865,346 172,724
2023-12-31 $296,670 33,000
2023-12-31 $296,670 33,000
2023-12-31 $1,963,838 218,447
2023-09-30 $992,446 127,728
2023-06-30 $485,296 50,134
2023-03-31 $744,764 67,953
2022-12-31 $279,603 64,723
2022-09-30 $4,939,151 656,802
2022-06-30 $10,462,591 1,041,054
2022-03-31 $5,494,218 443,798
2021-12-31 $713,544 31,200
2021-12-31 $12,217,313 534,207
2021-12-31 $1,429,375 62,500
2021-09-30 $13,163,056 594,806
2021-06-30 $2,473,493 190,856
2021-03-31 $5,392,150 415,260
2020-12-31 $2,199,301 159,024
2020-09-30 $3,270,413 222,024
2020-06-30 $1,262,397 77,686
2020-03-31 $1,127,223 77,686